Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc. is a biotechnology company specializing in the research and development of vaccines to prevent infectious diseases globally. The company's lead vaccine programs, BWV-101 and BWV-102, are in preclinical development for influenza and H1 pre-pandemic vaccines, respectively. Additionally, it has a pipeline of other preclinical programs targeting streptococcus pneumoniae induced acute otitis media, norovirus-rotavirus, and norovirus-malaria. Blue Water Vaccines generates revenue through the development and potential commercialization of these vaccines to address critical public health needs.